Neuropathological and Neuropsychiatric Determinants in HCV- Infected Patients
Reference14 articles.
1. Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus infection: New estimates of age-specific antibody to HCV seroprevalence. Hepatology. 2013;57:1333-1342. DOI: 10.1002/hep.26141 23172780 2. Jacobson IM, Cacoub P, Dal Maso L, Harrison SA, Younossi ZM. Manifestations of chronic hepatitis C virus infection beyond the liver. Clinical Gastroenterology and Hepatology. 2010;8(12):1017-1029 3. Monaco S, Ferrari (S), Gajofatto A, Zanusso G, Mariotto S. HCV-Related Nervous System Disorders. Clinical and Developmental Immunology, vol. 2012, Article ID 236148, 9 pages, 2012. doi:10.1155/2012/236148 4. Mathew S, Faheem M, Ibrahim SM, Iqbal W, Rauff B, Fatima K, Qadri I. Hepatitis C virus and neurological damage. World Journal of Hepatology. 2016;8(12):545-556. DOI: 10.4254/wjh.v8.i12.545 5. Adinolfi LE, Nevola R, Lus G, Restivo L, Guerrera B, Romano C, Zampino R, Rinaldi L, Sellitto A, Giordano M, Marrone A. Chronic hepatitis C virus infection and neurological and psychiatric disorders: An overview. World Journal of Gastroenterology. 2015;21(8):2269-2280. DOI: 10.3748/wjg.v21.i8.2269
|
|